Gilder Gagnon Howe & Co’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-79,803	Closed	-$2.23M	–	295
2016 Q3	$2.23M	Buy	79,803 +2,415	+3%	+$81K	0.04%	160
2016 Q2	$2.71M	Sell	77,388 -2,486	-3%	-$78.1K	0.05%	150
2016 Q1	$2.19M	Buy	+79,874	New	+$2.35M	0.04%	145
2015 Q4	–	Sell	-89,491	Closed	-$2.57M	–	275
2015 Q3	$2.57M	Buy	89,491 +1,479	+2%	+$63.2K	0.04%	160
2015 Q2	$3.94M	Sell	88,012 -51,548	-37%	-$1.94M	0.05%	166
2015 Q1	$4.83M	Sell	139,560 -443	-0.3%	-$12.1K	0.07%	142
2014 Q4	$3.83M	Buy	+140,003	New	+$3.4M	0.06%	154

Other funds holding DPLO

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Gilder Gagnon Howe & Co's DPLO Position: Q4 2016 in Review

Gilder Gagnon Howe & Co sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2016, closing a stake of 79,803 shares — an estimated $2.23M sold.

Gilder Gagnon Howe & Co first reported a position in DPLO in Q4 2014 and held it in 7 quarters. The position peaked at $4.83M in Q1 2015. 174 funds tracked by Wall St. Rank hold DPLO as of Q4 2016.

Gilder Gagnon Howe & Co reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2016 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 79,803 DIPLOMAT PHARMACY, INC. shares in Q4 2016, an estimated $2.23M.
Gilder Gagnon Howe & Co first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 7 quarters.
Gilder Gagnon Howe & Co's DIPLOMAT PHARMACY, INC. position peaked at $4.83M in Q1 2015.
174 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2016.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2016, filed 1 Feb 2017.